Work

A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer

Year: 2019

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.01.012

Authors: Hye Joung Choi, Jin Hyung Heo, Ju Yeon Park, Ju Yeon Jeong, Hyeon Ju Cho, Kyung Soon Park, Se Hwa Kim, Yong Wha Moon, Jin Sung Kim, Hee Jung An

Institutions: CHA University Bundang Medical Center, CHA University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Ministry of Health and Welfare, Korea Health Industry Development Institute

Award: G4900341305

OpenAlex ID: W2911528643

FWCI: 2.784

Cites: 35

Cited by: 66

Related to: 10